Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 29, 2011
Patent Application Number
11780133
Date Filed
July 19, 2007
Patent Primary Examiner
Patent abstract
The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
